16Mar 2020

BIO-EQUIVALENCE STUDY OF TWO INJECTABLE TILMICOSIN FORMULATIONS (MICOTIL 300 AND COZINA 300) IN CALVES

  • Professor and Head of Pharmacology Department, Faculty of Veterinary Medicine, Benha University, Egypt.
  • Assistant Professor of Pharmacology, Faculty of Veterinary Medicine, Benha University, Egypt.
Crossref Cited-by Linking logo

  • Abstract
  • References
  • Cite This Article as
  • Corresponding Author

The present study was designed to assess the comparative bio-equivalence of Micotil 300? and Cozina 300? in healthy Calves after SC injection of both products in a dose of 10 mg tilmicosin base/kg.b.wt. Ten calves were divided equally into two groups (5 calves for each group). The first group was designed to study the pharmacokinetics of Micotil 300?, while the 2nd group was designed to study the pharmacokinetics of Cozina 300?. Each calf in both groups was SC injected with 10 mg tilmicosin/kg.b.wt. Blood samples were obtained from the jugular vein and collected immediately before and at 0.08, 0.16, 0.25, 0.5, 1, 2, 4, 6, 8, 12 and 24 hours after a single SC injection. The disposition kinetics of Micotil 300? and Cozina 300? following SC injection of 10 mg tilmicosin/kg.b.wt. revealed that the maximum blood concentration [Cmax] were 4.01 and 3.53 μg/ml and attained at [tmax] of 1.82 and 1.83 hours, respectively. In conclusion: Cozina 300? is bioequivalent to Micotil 300?since the ratios of Cmax, AUC0-24 andAUC0-∞ (T/R) were 0.88, 0.87 and 0.89 respectively. These are within the Bio-equivalence acceptance range. Micotil 300? and Cozina 300?are therefore bioequivalent and interchangeable.

  1. Arret, B.;?Johnson, D.P. and?Kirshbaum, A. (1971). Outline of details for microbiological assays of antibiotics: second revision. J Pharm Sci.60(11):1689-1694.
  2. Baggot, J.D. (2001). The physiological Basis of veterinary clinical pharmacology. 1st ed. Blackwell, London.
  3. Chen, M.L., V. Shah, R. Patnaik, W. Adams, A. Hussain, D. Conner, M. Mehta, H. alinowski, J. Lazor, S.M. Huang, D. Hare, L. Lesko, D. Sporn and R. Williams, (2001). Bioavailability and Bio-equivalence: An FDA regulatory overview. Pharmaceutical Res., 18: 1645-1650.
  4. Crosier, K.K., Riviere, J.E. & Craigmill, A.L., eds. (1996) Tilmicosin phosphate. In The Food Animal Residue Avoidance Databank. A Comprehensive Compendium of Food Animal Drugs, 10th edn, p. 386. Publications and Distribution Center, University of Florida, Gainesville, FL.
  5. Dimitrova D., Petkov P., Tsoneva D. (2012) Pharmacokinetics of tilmicosin in calves after single subcutaneous application. Agricultural Science and Technology. 4(3): 211-214.
  6. El-Hewaity‏ M (2016) Effect of three anticoccidials on pharmacokinetics of tilmicosin in broiler chickens.‏ International Journal of Pharmacology and Toxicology 4 (2), 150-153‏
  7. EMEA (2002) Guidelines for the conduct of Bio-equivalence studies for veterinary medicinal products,1-11[http://www. emea.eu.int/pdfs/vet/ewp/001600en.pdf]2001. Accessed: 30.12.2002.
  8. (2006) The European Agency for Evaluation of Medicinal Products. Questions and Answers on Bioavailability and Bio-equivalence Guidance.
  9. Federal Register, Rules and Regulations (1996) Tilmicosin Phosphate Type A Medicated Article. In Federal Register, 61 (250): 68147-68148. Department of Health and Human Services, Food and Drug Administration.
  10. Freedman, R.A., Anderson, K.P., Green, L.S. & Mason, J.W. (1987) Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. American Journal of Cardiology, 59, 168-169.
  11. Hartman, E.G. and Geryl, J. (1993) Comparison between the Minimal Inhibitory Concentration of Tilmicosin and Oxytetracycline for Bovine Pneumonic Pasteurella haemolytica Isolates. Veterinary Quarterly, 15, 184. http://dx.doi.org/10.1080/01652176.1993.9694404
  12. Hartman, E.G. and Geryl, J. (1993) Comparison between the Minimal Inhibitory Concentration of Tilmicosin and Oxytetracycline for Bovine Pneumonic Pasteurella haemolytica Isolates. Veterinary Quarterly, 15, 184. http://dx.doi.org/10.1080/01652176.1993.9694404.
  13. Jordan, W.H., Byrd, R.A., Cochrane, R.L., Hanasono, G.K., Hoyt, J.A., Main, B.W., Meyerhoff, R.D. & Sarazan, R.D. (1993) A review of the toxicology of the antibiotic MICOTIL 300. Veterinary and Human Toxicology, 35, 151-158.
  14. Lombardi KR, Portillo T, Hassfurther R, Hunter RP. (2011) Pharmacokinetics?of?tilmicosin?in beef cattle following intravenous and subcutaneous administration.J Vet Pharmacol Ther. 34(6):583-7.
  15. Modric S, Webb AI, Derendorf H. (1998) Pharmacokinetics?and?pharmacodynamics?of?tilmicosin?in?sheep?and?cattle. J Vet Pharmacol Ther. 21(6):444-52.
  16. Musser, J., Mechor, G.D., Grohn, Y.T., Dubovi, E.J. and Shin, S. (1996) Comparison of Tilmicosin in with Long- Acting Oxytetracycline for Treatment of Respiratory Tract Disease in Calves. Journal of the American Veterinary Medical Association, 208, 102-106.
  17. Periti, P., Mazzei, T., Mini, E. & Novelli, A. (1993) Adverse effects of macrolide antibacterials. Drug Safety, 9, 346-364.
  18. Rowlan M and Tozer TN (1989) Clinical Pharmacology: Concepts and Applications. 2nd ed. Philadelphia: Lea & Febiger, 479-483.
  19. Scott, P.R. (1995) A Field Study of Respiratory Disease Affecting Housed Beef Calves in the United Kingdom. Cattle Practice, 3, 393-401.
  20. Soliman, A. M. and Sedek, M. (2016) Pharmacokinetics and Tissue Residues of Tylosin in Broiler Chickens. Pharmacology & Phar-macy, 7, 36-42.
  21. Tamargo, J., De Miguel, B. & Tejerina, M.T. (1982) A comparison of josamycin with macrolides and related antibiotics on isolated rat atria. European Journal of Pharmacology, 80, 285-293.
  22. Thompson, T.D., Laudert, S.B., Chamberland, S. and Lawrence, K. (1994) Micotil: Pharmacokinetics of Tilmicosin, a Semi-Synthetic Macrolide Antibiotic, in Acutely Pneumonic Cattle and Primary Bovine Alveolar Macrophages. 6th European Association for Vet Pharmacology and Therapeutics Congress, Edinburgh, 7-11 August 1994, 31-32.
  23. Toutain, P.L. and A. Bousquet-Melou, (2004) Bioavailability and its assessment. J. Pharmacol. Therap., 27: 455-466.
  24. S. Food and Drug Administration.?(2003)?Guidance for industry: bioavailability and Bio-equivalence studies for orally administered drug products.U.S. Food and Drug Administration,?Washington, DC.
  25. Wakabayashi, K. & Yamada, S. (1972) Effects of several macrolide antibiotics on blood pressure of dogs. Japanese Journal of Pharmacology, 22, 799-807.

[Ashraf Elkomy and Mohamed Aboubakr (2020); BIO-EQUIVALENCE STUDY OF TWO INJECTABLE TILMICOSIN FORMULATIONS (MICOTIL 300 AND COZINA 300) IN CALVES Int. J. of Adv. Res. 8 (Mar). 152-157] (ISSN 2320-5407). www.journalijar.com

Mohamed Aboubakr
Pharmacology, Department, Faculty of Veterinary Medicine, Benha University, Egypt

DOI:

Article DOI: 10.21474/IJAR01/10609      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10609

Download Full Paper

Download PDF No. of Downloads: 15 | No. of Views: 67